Microbot Medical Inc. - Common Stock (MBOT)

Advanced Robotics Are Reshaping Medicine

Microbot Medical shares are trading higher by 33% during Monday's session. The company is raising $7 million through stock sales and investment options.

U.S. stock futures advanced on Monday after ending their losing streak on Friday. Futures of all four major indices rose in premarket trade.

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the second quarter of 2024.

Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption (IDE) application for its LIBERTY Endovascular Robotic Surgical System.

MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the first quarter of 2024.

MBOT stock results show that Microbot Medical missed analyst estimates for earnings per share the fourth quarter of 2023.

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&P 500 also fell, dropping, 0.33% to 4,767.78.